Fábio Fernandes et al. Murillo Oliveira Antunes Felix José Alvares Ramires Vinicius Machado Correia … Viviane Tiemi Hotta Juliano Novaes Cardoso Luciano Nastari Barbara Maria Ianni Marcelo Luiz Campos Vieira Charles Mady Jeffrey B. Geske Adelaide M. Arruda-Olson Alan Silva Martins Guilherme José dos Santos Ferreira Vagner Madrini Junior
Hypertrophic cardiomyopathy: potentially misleading nomenclature
In pathology, hypertrophy is the increase in cell size.³ In the heart, this suggests hypertrophy of cardiomyocytes, which can induce an anchoring bias, leading physicians to prioritize the diagnosis of sarcomeric hypertrophic cardiomyopathy, while diseases such as cardiac amyloidosis — where thickening is due to extracellular amyloid accumulation — are underdiagnosed.
This problem is exacerbated in echocardiographic reports, which often use “hypertrophic cardiomyopathy” nonspecifically. Although echocardiography is useful, it does not differentiate between thickening due to cellular hypertrophy or interstitial accumulation (infiltrative or storage diseases), making the term inadequate and potentially harmful in guiding clinical investigation and decisions.
[…]
